252 related articles for article (PubMed ID: 24793739)
1. In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands.
Gandin V; Tisato F; Dolmella A; Pellei M; Santini C; Giorgetti M; Marzano C; Porchia M
J Med Chem; 2014 Jun; 57(11):4745-60. PubMed ID: 24793739
[TBL] [Abstract][Full Text] [Related]
2. Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.
Porchia M; Dolmella A; Gandin V; Marzano C; Pellei M; Peruzzo V; Refosco F; Santini C; Tisato F
Eur J Med Chem; 2013 Jan; 59():218-26. PubMed ID: 23229057
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
4. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.
Santini C; Pellei M; Papini G; Morresi B; Galassi R; Ricci S; Tisato F; Porchia M; Rigobello MP; Gandin V; Marzano C
J Inorg Biochem; 2011 Feb; 105(2):232-40. PubMed ID: 21194623
[TBL] [Abstract][Full Text] [Related]
5. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
[TBL] [Abstract][Full Text] [Related]
7. New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity.
Marzano C; Pellei M; Alidori S; Brossa A; Lobbia GG; Tisato F; Santini C
J Inorg Biochem; 2006 Feb; 100(2):299-304. PubMed ID: 16387362
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity.
Kovala-Demertzi D; Staninska M; Garcia-Santos I; Castineiras A; Demertzis MA
J Inorg Biochem; 2011 Sep; 105(9):1187-95. PubMed ID: 21718655
[TBL] [Abstract][Full Text] [Related]
9. Mononuclear and binuclear sandwich copper(II) complexes with poly(pyrazolyl)borate ligands: syntheses, structures and properties.
Xing YH; Zhang XJ; Sun Z; Han J; Zhang YH; Zhang BL; Ge MF; Niu SY
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Dec; 68(5):1256-62. PubMed ID: 17368085
[TBL] [Abstract][Full Text] [Related]
10. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
11. Novel mixed-ligand copper(I) complexes: role of diimine ligands on cytotoxicity and genotoxicity.
Gandin V; Porchia M; Tisato F; Zanella A; Severin E; Dolmella A; Marzano C
J Med Chem; 2013 Sep; 56(18):7416-30. PubMed ID: 23964823
[TBL] [Abstract][Full Text] [Related]
12. Homoleptic phosphino copper(I) complexes with in vitro and in vivo dual cytotoxic and anti-angiogenic activity.
Gandin V; Trenti A; Porchia M; Tisato F; Giorgetti M; Zanusso I; Trevisi L; Marzano C
Metallomics; 2015 Nov; 7(11):1497-507. PubMed ID: 26190698
[TBL] [Abstract][Full Text] [Related]
13. Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.
Massoud SS; Louka FR; Ducharme GT; Fischer RC; Mautner FA; Vančo J; Herchel R; Dvořák Z; Trávníček Z
J Inorg Biochem; 2018 Mar; 180():39-46. PubMed ID: 29232637
[TBL] [Abstract][Full Text] [Related]
14. Copper(I)-Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity.
Villarreal W; Colina-Vegas L; Visbal G; Corona O; Corrêa RS; Ellena J; Cominetti MR; Batista AA; Navarro M
Inorg Chem; 2017 Apr; 56(7):3781-3793. PubMed ID: 28290674
[TBL] [Abstract][Full Text] [Related]
15. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
[TBL] [Abstract][Full Text] [Related]
16. In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
Marzano C; Gandin V; Pellei M; Colavito D; Papini G; Lobbia GG; Del Giudice E; Porchia M; Tisato F; Santini C
J Med Chem; 2008 Feb; 51(4):798-808. PubMed ID: 18251492
[TBL] [Abstract][Full Text] [Related]
17. The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo-A Comparison of O,O-, S,O-, and N,N-Chelate Effects.
Berasaluce I; Cseh K; Roller A; Hejl M; Heffeter P; Berger W; Jakupec MA; Kandioller W; Malarek MS; Keppler BK
Chemistry; 2020 Feb; 26(10):2211-2221. PubMed ID: 31560142
[TBL] [Abstract][Full Text] [Related]
18. Cu
Bykowska A; Komarnicka UK; Jeżowska-Bojczuk M; Kyzioł A
J Inorg Biochem; 2018 Apr; 181():1-10. PubMed ID: 29348049
[TBL] [Abstract][Full Text] [Related]
19. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
[TBL] [Abstract][Full Text] [Related]
20. Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines.
O'Connor M; Kellett A; McCann M; Rosair G; McNamara M; Howe O; Creaven BS; McClean S; Kia AF; O'Shea D; Devereux M
J Med Chem; 2012 Mar; 55(5):1957-68. PubMed ID: 22313179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
